Pt(IV) complexes conjugating with chalcone analogue as inhibitors of microtubule polymerization exhibited selective inhibition in human cancer cells

Eur J Med Chem. 2018 Feb 25:146:435-450. doi: 10.1016/j.ejmech.2018.01.075. Epub 2018 Feb 4.

Abstract

Six novel of Pt(IV) complexes comprising chalcone analogues were synthesized and evaluated for anti-proliferative activity using MTT assay. In vitro evaluation revealed that all Pt(IV) complexes showed better and more potent activity against three human cancer cells including CDDP resistant cells than that of their corresponding mother Pt(II) species. Among them, two representative complexes, 14 and 17, exhibited better cell selectivity between cancer cells and normal cells than CDDP. Molecular docking study indicated that complexes 14 and 17 could bind to the colchicine site of tubulin. Moreover, complexes 14 and 17 also remarkably displayed inhibition of cell migration against HUVEC cells in vitro. Molecular mechanism studies suggested that 14 and 17 induced production of reactive oxygen species (ROS), cell cycle arrest at the G2/M phase, and mitochondria-mediated apoptosis by regulating the expression of Bcl-2 family members.

Keywords: Anticancer activity; Apoptosis; Pt(IV) complex; Tubulin polymerization.

MeSH terms

  • Antineoplastic Agents / chemical synthesis
  • Antineoplastic Agents / chemistry
  • Antineoplastic Agents / pharmacology*
  • Cell Proliferation / drug effects
  • Cells, Cultured
  • Chalcone / chemistry
  • Chalcone / pharmacology*
  • Dose-Response Relationship, Drug
  • Drug Screening Assays, Antitumor
  • Humans
  • Microtubules / drug effects*
  • Microtubules / metabolism
  • Molecular Structure
  • Organoplatinum Compounds / chemistry
  • Organoplatinum Compounds / pharmacology*
  • Polymerization / drug effects
  • Structure-Activity Relationship

Substances

  • Antineoplastic Agents
  • Organoplatinum Compounds
  • Chalcone